Advances in Laser Technology for Photocoagulation
Laser photocoagulation is a mainstay of retinal practice, having been validated as an effective treatment for
clinically significant macular edema associated with diabetic retinopathy and retinal vein occlusions in landmark studies. This article discusses two important advances in laser photocoagulation technology and their impact on patient outcomes.
577 nm Wavelength System Delivers Safety
While the original diode lasers had revolutionary capabilities when they debuted, the systems were somewhat problematic for patient comfort. The high wavelengths caused pain when near-infrared light would pass through blood and was absorbed by the RPE. This
article discusses The Pascal Streamline 577 from Topcon Medical, a solid-state, yellow- wavelength system that gives surgeons full control over laser parameters.
The Benefits of a Multi-wavelength PatternScanLaser
The impetus behind adopting new technology is not merely to have the latest and greatest equipment. It is more about being able to practice medicine at the
most advanced level and improving the patient’s experience whenever possible. This article applies that logic to the assessment of the benefits delivered by
the Multi-wavelength PatternScanLaser.
Finding “Big Ideas” in Ophthalmic Innovation
Ophthalmologists are well-known for coming up with original ideas for devices and instruments that allow them to treat patients in a more efficient and cost-effective manner. But if you're thinking of bringing your concept to an ophthalmic company or well-respected venture capital firm, this paper discusses why it should offer more than an incremental improvement over what's currently available in the marketplace.
Adding Retina to a Comprehensive Ophthalmology Practice
Over the past 25 years, several factors have increased the demand for vitreoretinal subspecialist services: the increasing population of baby-boomers, increasing development of treatment options, improvements in surgical instrumentation and outcomes, and an increasing concern about medicolegal considerations in areas that have other retinal physicians readily available to treat potentially blinding emergencies. This paper discusses the ins and outs of expanding to the posterior segment.
A Glimpse at New and Emerging Treatments for DME
The quest to preserve vision in diabetic eye disease is focusing on anti-VEGF drugs, implants and topical drops. DME management in the past few years has changed dramatically, though. At present anti-VEGF and steroids are the most commonly used treatment modalities along with variable combinations, and some of the most promising treatments are still emerging. This paper looks at these emerging drug-delivery technologies and new drugs, which promise to deliver improved results.